NEXI

NexImmune Inc. (NEXI) | Rumor.io

NexImmune

NEXI

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-32.3M

Social

What share of all stock conversation is about NEXI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Apr 17

NEXI is a biotechnology company developing personalized immunotherapies.
The company's stock price has been volatile in recent months, with some analysts predicting a potential turnaround.
NexImmune's focus on cancer and autoimmune diseases may lead to significant breakthroughs in the field of immunotherapy.

Generated by AI

Sentiment

Of the messages about NEXI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	76.92% -10.76
Bearish	—	—	0% 0	23.08% +10.76

Bullish· Mar 11

The team behind NexImmune, Inc. has a successful track record, with one of their previous projects reaching a market capitalization of ~$1.2B.
The company's airdrop and lack of VC involvement suggest a low risk of rugpull, making $NEXI a potentially safe investment.
With a 50,000 USDT reward pool, the $NEXI Listing Carnival is an attractive event for traders, offering a significant bonus for participating.

Bearish· Mar 9

The company has been accused of scamming its community, with some users claiming they were misled about the token's potential value.
The team behind the project is alleged to have dumped their own tokens, contributing to the asset's sharp price drop.
The project has been deemed a failure, with some users expressing disappointment and frustration with the company's handling of the token's listing and distribution.

Generated by AI

Topics

Of the messages about NEXI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	17.39%
Announcements	—	—	100%	67.39%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	15.22%
Technical Analysis	—	—	0%	0%

Announcements· Mar 9

$NEXI (Nexira DAEP) is listed on LBank and will be available for trading.
Nexira DAEP is a unified gaming ecosystem built by the creators of Heroes of Mavia (MAVIA), designed to connect multiple titles through a shared economy.
$NEXI will be transferred to the Nexira DAEP trading wallet, and non-airdrop Ruby will be eligible for exchange for $NEXI at Nexira DAEP Pair-Launch.

Technical Analysis· Jan 30

$NEXI has broken through resistance levels, with potential next resistances at $16.5, $18, and $20.
The stock is showing signs of a bull flag, with a strong support zone at $8.3-$8.8 and a potential target of $10.9-$11.75.
The stock has been experiencing a significant squeeze, with potential shorting opportunities above $30, and a possible next leg up in the mid $20s.

Generated by AI

Community

Of the messages about NEXI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	80%	0.59%
Newcomers	—	—	20%	99.41%

Regulars· Feb 5

Regular investors who followed NexImmune, Inc. (NEXI) are comparing its current price action to a previous significant move from $1.30 to over $11, which resulted in a 1000% gain.
The comparison is based on similarities between the two scenarios, including the company's initial lack of a business plan and its potential for future growth.
Despite the current -9.05% pre-market drop, regular investors are awaiting a hearing that could potentially impact the stock's price.

Newcomers· Oct 17

Many newcomers are discussing NexImmune, Inc. (NEXI) in the context of its potential as an AI-driven stock, but there are questions about its long-term sustainability.
Some are comparing NexImmune, Inc. (NEXI) to Nixxy (NIXX), wondering if it has the potential to become a future AI giant or is just another stock on a wild ride.
There is skepticism about the stock's value, with some questioning whether the optimism surrounding NexImmune, Inc. (NEXI) is justified, or if it's just another meme stock.

Generated by AI

Also Discussed

Investors talking about NEXI also mention

#	Name	Attention
1	MINM - Minim, Inc.	——
2	Sera Prognostics, Inc. Class A Common StockSERA	0%0
3	OMGA - Omega Therapeutics, Inc.	——
4	Sentage Holdings Inc.SNTG	0%0
5	iShares ESG Advanced Total USD Bond Market ETFEUSB	0%0
6	SMFL - Smart for Life, Inc.	——
7	Vivos Therapeutics, Inc.VVOS	0%+0
8	Cingulate Inc.CING	0%new
9	TPHS - Trinity Place Holdings Inc.	——
10	MLNK - MeridianLink, Inc.	——

NexImmune Inc.

Healthcare
Biotechnology

NexImmune Inc. is a biotechnology company that specializes in developing innovative immune therapies to combat difficult-to-treat cancers and other life-threatening diseases. Its primary function is to harness the power of the immune system through its proprietary AIM (Artificial Immune Modulation) technology platform. This platform is designed to recruit, train, and activate T cells, a critical component of the immune system, to target and eliminate harmful cells. The company's focus is primarily on research that impacts the biopharmaceutical and healthcare sectors, aiming to provide breakthroughs in immunotherapy treatments with potentially fewer side effects compared to traditional therapies. Headquartered in Gaithersburg, Maryland, NexImmune is at the forefront of cutting-edge cancer research, contributing significantly to the advancement of personalized medicine. NexImmune's significance in the financial market lies in its innovative approach to treating cancer and other diseases, appealing to investors interested in the biotechnology sector, particularly those focused on immuno-oncology. Its developments and trials are closely watched by analysts seeking to gauge the future landscape of therapeutic solutions."}

Website

Location

9119 Gaither Road

Gaithersburg, MD, 20877

United States

Social

What share of all stock conversation is about NEXI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Apr 17

NEXI is a biotechnology company developing personalized immunotherapies.
The company's stock price has been volatile in recent months, with some analysts predicting a potential turnaround.
NexImmune's focus on cancer and autoimmune diseases may lead to significant breakthroughs in the field of immunotherapy.

Generated by AI

Sentiment

Of the messages about NEXI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	76.92% -10.76
Bearish	—	—	0% 0	23.08% +10.76

Bullish· Mar 11

The team behind NexImmune, Inc. has a successful track record, with one of their previous projects reaching a market capitalization of ~$1.2B.
The company's airdrop and lack of VC involvement suggest a low risk of rugpull, making $NEXI a potentially safe investment.
With a 50,000 USDT reward pool, the $NEXI Listing Carnival is an attractive event for traders, offering a significant bonus for participating.

Bearish· Mar 9

The company has been accused of scamming its community, with some users claiming they were misled about the token's potential value.
The team behind the project is alleged to have dumped their own tokens, contributing to the asset's sharp price drop.
The project has been deemed a failure, with some users expressing disappointment and frustration with the company's handling of the token's listing and distribution.

Generated by AI

Topics

Of the messages about NEXI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	17.39%
Announcements	—	—	100%	67.39%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	15.22%
Technical Analysis	—	—	0%	0%

Announcements· Mar 9

$NEXI (Nexira DAEP) is listed on LBank and will be available for trading.
Nexira DAEP is a unified gaming ecosystem built by the creators of Heroes of Mavia (MAVIA), designed to connect multiple titles through a shared economy.
$NEXI will be transferred to the Nexira DAEP trading wallet, and non-airdrop Ruby will be eligible for exchange for $NEXI at Nexira DAEP Pair-Launch.

Technical Analysis· Jan 30

$NEXI has broken through resistance levels, with potential next resistances at $16.5, $18, and $20.
The stock is showing signs of a bull flag, with a strong support zone at $8.3-$8.8 and a potential target of $10.9-$11.75.
The stock has been experiencing a significant squeeze, with potential shorting opportunities above $30, and a possible next leg up in the mid $20s.

Generated by AI

Community

Of the messages about NEXI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	80%	0.59%
Newcomers	—	—	20%	99.41%

Regulars· Feb 5

Regular investors who followed NexImmune, Inc. (NEXI) are comparing its current price action to a previous significant move from $1.30 to over $11, which resulted in a 1000% gain.
The comparison is based on similarities between the two scenarios, including the company's initial lack of a business plan and its potential for future growth.
Despite the current -9.05% pre-market drop, regular investors are awaiting a hearing that could potentially impact the stock's price.

Newcomers· Oct 17

Many newcomers are discussing NexImmune, Inc. (NEXI) in the context of its potential as an AI-driven stock, but there are questions about its long-term sustainability.
Some are comparing NexImmune, Inc. (NEXI) to Nixxy (NIXX), wondering if it has the potential to become a future AI giant or is just another stock on a wild ride.
There is skepticism about the stock's value, with some questioning whether the optimism surrounding NexImmune, Inc. (NEXI) is justified, or if it's just another meme stock.

Generated by AI

NexImmune

Social

Apr 17

Sentiment

Bullish· Mar 11

Bearish· Mar 9

Topics

Announcements· Mar 9

Technical Analysis· Jan 30

Community

Regulars· Feb 5

Newcomers· Oct 17

Also Discussed

NexImmune Inc.

Company Information

Location

Also Discussed

Social

Apr 17

Sentiment

Bullish· Mar 11

Bearish· Mar 9

Topics

Announcements· Mar 9

Technical Analysis· Jan 30

Community

Regulars· Feb 5

Newcomers· Oct 17